Simplicity Solutions’s United Therapeutics UTHR Stock Holding History

Simplicity Solutions’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,506	Closed	-$270K	–	705
2022 Q1	$270K	Buy	+1,506	New	+$287K	0.03%	494
2021 Q4	–	Sell	-1,630	Closed	-$301K	–	611
2021 Q3	$301K	Buy	1,630 +66	+4%	+$13K	0.05%	435
2021 Q2	$281K	Sell	1,564 -106	-6%	-$20.2K	0.06%	405
2021 Q1	$279K	Sell	1,670 -121	-7%	-$20.2K	0.06%	367
2020 Q4	$272K	Buy	+1,791	New	+$235K	﹤0.01%	805
2016 Q1	–	Sell	-3,300	Closed	-$517K	–	510
2015 Q4	$517K	Buy	+3,300	New	+$480K	0.06%	444

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Simplicity Solutions's UTHR Position: Q2 2022 in Review

Simplicity Solutions sold out of United Therapeutics (UTHR) in Q2 2022, closing a stake of 1,506 shares — an estimated $270K sold.

Simplicity Solutions first reported a position in UTHR in Q4 2015 and held it in 6 quarters. The position peaked at $517K in Q4 2015. 472 funds tracked by Wall St. Rank hold UTHR as of Q2 2022.

Simplicity Solutions reported no remaining United Therapeutics position as of Q2 2022 after selling out during the quarter.
Simplicity Solutions sold 1,506 United Therapeutics shares in Q2 2022, an estimated $270K.
Simplicity Solutions first reported a position in United Therapeutics in Q4 2015 and held it in 6 quarters.
Simplicity Solutions's United Therapeutics position peaked at $517K in Q4 2015.
472 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2022.

Based on Simplicity Solutions's 13F filing for Q2 2022, filed 19 Jul 2022.